La viruela del simio es rara en niños y adolescentes, y pocas veces resulta letal, según los CDC
JUEVES, 3 de noviembre de 2022 (HealthDay News) — De más de 25,000 casos de viruela del simio de EE. UU. que revisó un nuevo estudio, apenas un 0.3 por ciento ocurrieron en personas menores de 18 años, muestran nuevos datos del gobierno.La mayoría de…
Learn MoreMonkeypox Can Be Passed On Even Before Symptoms Appear
THURSDAY, Nov. 3, 2022 (HealthDay News) — Monkeypox spreads even before a person shows any telltale lesions or other symptoms, a new study suggests.More than half of monkeypox transmission in the United Kingdom occurred in the pre-symptomatic phase, …
Learn MoreMonkeypox in Kids, Teens Is Rare and Seldom Severe: CDC
THURSDAY, Nov. 3, 2022 (HealthDay News) — Out of the more than 25,000 U.S. cases of monkeypox reviewed in a new study, just 0.3% occurred in people under the age of 18, new government data shows.Most of the kids and teens who contracted the virus — …
Learn MoreLa primera relación sexual fomenta la respuesta inmunitaria vaginal, encuentra un estudio
VIERNES, 28 de octubre de 2022 (HealthDay News) — El cuerpo de una mujer parece entrar en estado de alerta cuando pierde la virginidad, informa un estudio reciente.En específico, su sistema inmunitario aumenta la actividad en su vagina tras el primer…
Learn MoreFirst Sex Activates Boost in Vaginal Immune Response, Study Finds
FRIDAY, Oct. 28, 2022 (HealthDay News) — A woman’s body appears to go on high alert after she loses her virginity, a new study reports.Specifically, her immune system ramps up activity in her vagina following her first sexual intercourse, researchers…
Learn MoreManifestations of Hospitalization With Severe Monkeypox Described
THURSDAY, Oct. 27, 2022 (HealthDay News) — Most patients hospitalized with severe manifestations of monkeypox have HIV infection, according to research published in the Oct. 26 early-release issue of the U.S. Centers for Disease Control and Preventi…
Learn MoreIDSA: Three-Dose Hepatitis B Vaccine Highly Protective in Persons With HIV
WEDNESDAY, Oct. 26, 2022 (HealthDay News) — For persons living with HIV (PLWH), a three-dose hepatitis B virus (HBV) vaccine adjuvanted to a TLR-9 agonist (HepB-CpG) yields 100 percent seroprotection, according to a study presented at the annual meet…
Learn MoreIDSA: Long-Term Follow-Up Reported for Early Initiation of ART in HIV
TUESDAY, Oct. 25, 2022 (HealthDay News) — Initiating antiretroviral treatment (ART) early in the course of HIV infection results in better outcomes compared with deferred initiation, although the difference in ongoing excess risk is reduced with long…
Learn MoreERs Seeing Huge Rise in Cases of Sexual Assault
FRIDAY, Oct. 21, 2022 (HealthDay News) — Victims of sexual assault are seeking treatment in U.S. emergency rooms in growing numbers, with University of Michigan (UM) researchers detecting a 15-fold increase between 2006 and 2019.Rapes and other forms…
Learn MoreComenzará en África un importante ensayo de TPOXX, el tratamiento para la viruela del simio
LUNES, 17 de octubre de 2022 (HealthDay News) — La capacidad de TPOXX de tratar a las personas infectadas con la viruela del simio se va a evaluar de forma directa en un nuevo ensayo en África Central, anunciaron las autoridades de salud de EE. UU. T…
Learn More